| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-05 |